Small Molecules

What’s going on in UK life sciences? How the government is offering support to the sector and investing in talent.

How small molecule-focused CDMOs can help companies navigate the impact of the Inflation Reduction Act.

How to mitigate the risks involved in highly potent APIs.

Exploring the potential of leriglitazone in helping patients with cerebral X-linked adrenoleukodystrophy.

As world leaders commit to an ambitious reduction in AMR-related deaths, we ask is five years enough time to achieve it?

Voting is now open for our 2025 Company of the Year Awards.

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

The material composition of consumables – whether plastic or glass – impacts their carbon footprints. But which is more efficient?

Research and development in sleep-wake disorders has been asleep on its feet

Sitting Down With … Piper Trelstad, Head of CMC, The Bill & Melinda Gates Medical Research Institute